| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |